Schattenberg, Joern M.; Straub, Beate K.
On the value and limitations of liver histology in assessing non-alcoholic steatohepatitisJOURNAL OF HEPATOLOGY. Bd. 73. H. 6. 2020 S. 1592-1593
Kaya, Sebahat; Zimmer, Stefanie; Kammerer, Peer Wolfgang
Palatal steatocystoma simplex-a rare oral finding at an even rarer locationJOURNAL OF SURGICAL CASE REPORTS. H. 10. 2020
Huang, Wenjie; Navarro-Serer, Bernat; Jeong, Yea Ji et al.
Pattern of Invasion in Human Pancreatic Cancer Organoids Is Associated with Loss of SMAD4 and Clinical OutcomeCANCER RESEARCH. Bd. 80. H. 13. 2020 S. 2804-2817
Amitay, Efrat L.; Carr, Prudence R.; Jansen, Lina et al.
Postmenopausal hormone replacement therapy and colorectal cancer risk by molecular subtypes and pathwaysINTERNATIONAL JOURNAL OF CANCER. 2020
Stenzel, Philipp J.; Schindeldecker, Mario; Tagscherer, Katrin E. et al.
Prognostic and Predictive Value of Tumor-infiltrating Leukocytes and of Immune Checkpoint Molecules PD1 and PDL1 in Clear Cell Renal Cell CarcinomaTRANSLATIONAL ONCOLOGY. Bd. 13. H. 2. 2020 S. 336-345
Watzka, F. M.; Meyer, F.; Staubitz, J. I. et al.
Prognostic Assessment of Non-functioning Neuroendocrine Pancreatic Neoplasms as a Basis for Risk-Adapted Resection Strategies (vol 44, pg 594, 2020)WORLD JOURNAL OF SURGERY. Bd. 44. H. 5. 2020 S. 1681-1681
Krishnan, Aswini; Berthelet, Jean; Renaud, Emilie et al.
Proteogenomics analysis unveils a TFG-RET gene fusion and druggable targets in papillary thyroid carcinomasNATURE COMMUNICATIONS. Bd. 11. H. 1. 2020
Buettner-Herold, Maike; Sticht, Carsten; Wiech, Thorsten et al.
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasmsHISTOPATHOLOGY. 2020
Noske, A.; Ammann, J.; Wagner, D. C. et al.
Reproducibility and concordance of 4 clinically developed programmed death-ligand 1 (PD-L1) immunohistochemistry (IHC) assays in triple-negative breast cancer (TNBC)GEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 80. H. 06. 2020 S. E50-E50
Noske, A.; Ammann, J.; Wagner, D-C et al.
Reproducibility and concordance of 4 clinically developed programmed death-ligand 1 (PD-L1) immunohistochemistry assays in triple-negative breast cancer (TNBC)ONCOLOGY RESEARCH AND TREATMENT. Bd. 43. H. SUPPL 4. 2020 S. 158-158